Alyeska Investment Group’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Hold	0	–	–	–	575
2024 Q1	–	Hold	0	–	–	–	531
2023 Q4	–	Sell	-2,617	Closed	-$512K	–	539
2023 Q3	$512K	Sell	2,617 -7,012	-73%	-$1.37M	﹤0.01%	430
2023 Q2	$1.96M	Buy	+9,629	New	+$1.96M	0.01%	385